Patents by Inventor Jyoti Asundi

Jyoti Asundi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-Ly6E antibodies and methods of use
    Patent number: 10889651
    Abstract: The invention provides anti-Ly6E antibodies, immunoconjugates and methods of using the same.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: January 12, 2021
    Assignee: Genentech, Inc.
    Inventors: Jyoti Asundi, Ron Firestein, Paul Polakis, Chie Sakanaka, Peter Chang, Rayna Takaki Venook
  • ANTI-Ly6E ANTIBODIES AND METHODS OF USE
    Publication number: 20190085089
    Abstract: The invention provides anti-Ly6E antibodies, immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 31, 2018
    Publication date: March 21, 2019
    Applicant: Genentech, Inc.
    Inventors: Jyoti Asundi, Ron Firestein, Paul Polakis, Chie Sakanaka, Peter Chang, Rayna Takaki Venook
  • Anti-PMEL17 antibodies and immunoconjugates
    Patent number: 10196454
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: February 5, 2019
    Assignee: Genentech, Inc.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • Anti-Ly6E antibodies and methods of use
    Patent number: 10066022
    Abstract: The invention provides anti-Ly6E antibodies, immunoconjugates and methods of using the same. In some embodiments, the anti-Ly6E antibodies comprise heavy chain HVRs comprising the amino acid sequences of SEQ ID NOs: 32-34 and/or light chain HVRs comprising the amino acid sequences of SEQ ID NOs: 29-31.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: September 4, 2018
    Assignee: Genentech, Inc.
    Inventors: Jyoti Asundi, Ron Firestein, Paul Polakis, Chie Sakanaka, Peter Chang, Rayna Takaki Venook
  • Compositions and methods for the diagnosis and treatment of tumor
    Patent number: 9815905
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: November 14, 2017
    Assignee: Genentech, Inc.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20170240645
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: February 6, 2017
    Publication date: August 24, 2017
    Applicant: GENENTECH, INC.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • Anti-PMEL17 antibodies and immunoconjugates
    Patent number: 9597411
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: March 21, 2017
    Assignee: Genentech, Inc.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • ANTI-Ly6E ANTIBODIES AND METHODS OF USE
    Publication number: 20170058042
    Abstract: The invention provides anti-Ly6E antibodies, immunoconjugates and methods of using the same.
    Type: Application
    Filed: February 8, 2016
    Publication date: March 2, 2017
    Inventors: Jyoti Asundi, Ron Firestein, Paul Polakis, Chie Sakanaka, Peter Chang, Rayna Takaki Venook
  • Anti-ETBR antibodies and immunoconjugates
    Patent number: 9464141
    Abstract: The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a pyrrolobenzodiazepine.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: October 11, 2016
    Assignee: Genentech, Inc.
    Inventors: Jyoti Asundi, Suzanna Clark, Paul Polakis
  • Anti-ETBR antibodies and immunoconjugates
    Patent number: 9463251
    Abstract: The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a nemorubicin derivative.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: October 11, 2016
    Assignee: Genentech, Inc.
    Inventors: Jyoti Asundi, Suzanna Clark, Paul Polakis
  • Anti-Ly6E antibodies and methods of use
    Patent number: 9290578
    Abstract: The invention provides anti-Ly6E antibodies, immunoconjugates and methods of using the same.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: March 22, 2016
    Assignee: Genentech, Inc.
    Inventors: Jyoti Asundi, Ron Firestein, Paul Polakis, Chie Sakanaka, Peter Chang, Rayna Takaki Venook
  • ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20150374847
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: May 6, 2015
    Publication date: December 31, 2015
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20150196660
    Abstract: The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a nemorubicin derivative.
    Type: Application
    Filed: August 1, 2013
    Publication date: July 16, 2015
    Inventors: Jyoti Asundi, Suzanna Clark, Paul Polakis
  • ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20150183883
    Abstract: The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a pyrrolobenzodiazepine.
    Type: Application
    Filed: August 1, 2013
    Publication date: July 2, 2015
    Inventors: Jyoti Asundi, Suzanna Clark, Paul Polakis
  • Anti-PMEL17 antibodies and immunoconjugates
    Patent number: 9056910
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: June 16, 2015
    Assignee: Genentech, Inc.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • ANTI-Ly6E ANTIBODIES AND METHODS OF USE
    Publication number: 20150132218
    Abstract: The invention provides anti-Ly6E antibodies, immunoconjugates and methods of using the same.
    Type: Application
    Filed: October 20, 2014
    Publication date: May 14, 2015
    Inventors: Jyoti Asundi, Ron Firestein, Paul Polakis, Chie Sakanaka, Peter Chang, Rayna Takaki Venook
  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
    Publication number: 20150023871
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 22, 2015
    Applicant: GENENTECH, INC.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • THERAPEUTIC COMBINATIONS AND METHODS OF TREATING MELANOMA
    Publication number: 20140341916
    Abstract: The invention provides therapeutic combinations of anti-ETBR antibodies and MAP kinase inhibitors and methods of using the same to treat melanoma.
    Type: Application
    Filed: October 24, 2012
    Publication date: November 20, 2014
    Applicant: GENENTECH, INC.
    Inventors: Paul Polakis, Jyoti Asundi, Suzanna Clark
  • Compositions and methods for the diagnosis and treatment of tumor
    Patent number: 8877897
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: November 4, 2014
    Assignee: Genentech, Inc.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES
    Publication number: 20130295007
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: April 30, 2013
    Publication date: November 7, 2013
    Applicant: GENENTECH, INC.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark